EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tumours of the foot: A 10 years retrospective analysis

Vivek Ajit Singh iD, Vinesh Sandhu, Choo Tze Yong, Nor Faissal Yasin iD

Journal of Orthopaedic Surgery · 2024

DOI: 10.1177/10225536241248706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Surgery, 2024. Verfasst von Vivek Ajit Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Orthopaedic Centre of Excellence in Research & Learning (NOCERAL), Department of Orthopaedic Surgery, Faculty of Medicine, University Malaya…. Hauptthemen laut MEDLINE: Soft Tissue Neoplasms, Bone Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The foot is a complex structure composed of several tissues, each of which can be the origin of the proliferation and development of the tumour. Most lesions about the foot are reactive or inflammatory, but some are true neoplasms.

Method

This is a retrospective analysis of 4997 patient records treated in the Orthopaedic Oncology Unit of University Malaya Medical Centre, Malaysia, between 1 January 2010 to 31 December 2020. Demographic data of 195 patients with foot tumours were analysed out of 4997 neoplasm patients.

Results

There were 195 cases of foot tumours: 148 were benign, and 47 were malignant. 47 were bone tumours, 4 were metastases, and 144 were soft tissue tumours. Six patients succumbed to the disease, two cases of giant cell tumour (GCT) and one patient with synovial sarcoma had a recurrence. Treatment of foot tumours was wide resection in general. However, in metastasis cases, amputation was done. The majority of tumours were in the toes and dorsum of the foot. Soft tissue tumours of the foot occur in the elderly population in contrast to bone tumours, mainly in the second decade of life. The gender distribution was almost equal for foot tumours. Ganglion and Giant Cell Tumour of the bone are the commonest benign soft tissue and bone tumours. The most common malignant soft tissue and bone tumours are malignant melanoma and chondrosarcoma. The amputation rate is 5.64% the recurrence rate is 1.54%. Mortality rate is 3.08%. The MSTS score is 79%, and the TESS score is 76.23%.

Conclusion

Foot tumours are relatively rare, mostly originating from soft tissue and exhibiting a benign nature. Nonetheless, a noteworthy proportion—approximately a quarter of these tumours—demonstrate malignancy. The surgical interventions undertaken in managing these tumours and associated functional outcomes generally yield acceptable results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Soft Tissue NeoplasmsBone NeoplasmsHumansRetrospective StudiesMaleFemaleMiddle AgedAdultAgedMalaysiaAdolescentYoung AdultChildFootAmputation, SurgicalAged, 80 and overFoot DiseasesChild, Preschool

Stichwörter der Autor:innen

clinical outcomefootfunctional outcometumours

Autor:innen und Institutionen

  • National Orthopaedic Centre of Excellence in Research & Learning (NOCERAL), Department of Orthopaedic Surgery, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
  • Division of Medicine, UCL Medical School, University College London (UCL), London, UK.

ORCID-Profile: Vivek Ajit Singh, Nor Faissal Yasin

Zitieren

APA

Ajit Singh, V., Sandhu, V., Tze Yong, C., & Yasin, N. F. (2024). Tumours of the foot: A 10 years retrospective analysis. Journal of Orthopaedic Surgery. https://doi.org/10.1177/10225536241248706

Vancouver

Ajit Singh V, Sandhu V, Tze Yong C, Yasin NF. Tumours of the foot: A 10 years retrospective analysis. Journal of Orthopaedic Surgery. 2024. doi:10.1177/10225536241248706

BibTeX
@article{AjitSingh2024,
  author = {Ajit Singh, Vivek and Sandhu, Vinesh and Tze Yong, Choo and Yasin, Nor Faissal},
  title = {Tumours of the foot: A 10 years retrospective analysis},
  journal = {Journal of Orthopaedic Surgery},
  year = {2024},
  doi = {10.1177/10225536241248706}
}
Kostenlos starten →